Cargando…

Recurrent Syncope and Cardiac Arrest in a Patient with Systemic Light Chain Amyloidosis Treated with Bortezomib

About 10-15% of patients with multiple myeloma develop light chain (AL) amyloidosis. AL amyloidosis is a systemic disease that may involve multiple organs, often including the heart. It may present clinically with bradyarrhythmia and syncope. The proteasome inhibitor bortezomib has been used with cl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jaipaul, Navin, Pi, Alexander, Zhang, Zhiwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PAGEPress Publications, Pavia, Italy 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961869/ https://www.ncbi.nlm.nih.gov/pubmed/27499835 http://dx.doi.org/10.4081/hr.2016.6417

Ejemplares similares

Rare and unusual clinicopathologic presentation of renal AL amyloidosis
por: Logan, Andrew, et al.
Publicado: (2016)

Vasovagal Syncope and Pulseless Electrical Activity Cardiac Arrest in Patients With Immunoglobulin Light Chain Cardiac Amyloidosis: A Case Series
por: Sperry, Brett W, et al.
Publicado: (2023)

Evaluation of Syncope Reveals Cardiac Amyloidosis
por: Lippmann, Matthew, et al.
Publicado: (2018)

Neuropathy and efficacy of once weekly subcutaneous bortezomib in multiple myeloma and light chain (AL) amyloidosis
por: Sidana, Surbhi, et al.
Publicado: (2017)

Light-chain cardiac amyloidosis: a case report of extraordinary sustained pathological response to cyclophosphamide, bortezomib, and dexamethasone combined therapy
por: Porcari, Aldostefano, et al.
Publicado: (2022)

Efficacy of bortezomib, cyclophosphamide and dexamethasone in cardiac AL amyloidosis
por: Brennan, Xavier, et al.
Publicado: (2022)

Light chain cardiac amyloidosis in a nonagenarian
por: Takahashi, Koji, et al.
Publicado: (2022)

Feature tracking cardiac magnetic resonance in systemic light chain amyloidosis
por: Kammerer, Rebekka, et al.
Publicado: (2013)

Cardiac magnetic resonance strain imaging in systemic light chain amyloidosis
por: Andre, Florian, et al.
Publicado: (2014)

Pomolidomide for relapsed/refractory light chain amyloidosis after resistance to both bortezomib and daratumumab: A case report
por: Li, Xian, et al.
Publicado: (2022)

Cardiac Amyloidosis Responding to Bortezomib: Case Report and Review of Literature
por: Charaf, Edriss, et al.
Publicado: (2009)

Physiology, Diagnosis and Treatment of Cardiac Light Chain Amyloidosis
por: Stelmach-Gołdyś, Agnieszka, et al.
Publicado: (2022)

Light Chain Amyloidosis
por: Milani, Paolo, et al.
Publicado: (2018)

Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteria
por: Sharpley, Faye A., et al.
Publicado: (2020)

Bortezomib-based induction followed by stem cell transplantation in light chain amyloidosis: results of the multicenter HOVON 104 trial
por: Minnema, Monique C., et al.
Publicado: (2019)

Predictor of Syncopal Recurrence in Children With Vasovagal Syncope Treated With Metoprolol
por: Tao, Chunyan, et al.
Publicado: (2022)

Effectiveness of Bortezomib in Cardiac AL Amyloidosis: A Report of Two Cases
por: Nigrelli, Santi, et al.
Publicado: (2014)

Light-chain cardiac amyloidosis with neuropathy: a case report
por: Xu, Zhan-Wen, et al.
Publicado: (2015)

Cardiac involvement in light chain amyloidosis: a case report
por: Li, Jing, et al.
Publicado: (2020)

Predictors of Mortality in Light Chain Cardiac Amyloidosis with Heart Failure
por: Tahir, Usman A., et al.
Publicado: (2019)

Light Chain (AL) Cardiac Amyloidosis: A Diagnostic Dilemma
por: Abdelazeem, Basel, et al.
Publicado: (2021)

Light-chain cardiac amyloidosis for the non-expert: pearls and pitfalls
por: De Michieli, Laura, et al.
Publicado: (2023)

Response of Bortezomib Chemotherapy in Hepatic Amyloidosis
por: Hasan, Syed M., et al.
Publicado: (2018)

Case Report: Management of Primary Tracheobronchial Light Chain Amyloidosis in a Patient With Biclonal Gammopathy Using a Systemic Bortezomib-Based Regimen
por: Yan, Wei, et al.
Publicado: (2021)

Recent advances in understanding and treating immunoglobulin light chain amyloidosis
por: Badar, Talha, et al.
Publicado: (2018)

Restrictive Atrial Dysfunction in Cardiac Amyloidosis: Differences between Immunoglobulin Light Chain and Transthyretin Cardiac Amyloidosis Patients
por: Versteylen, Mathijs O., et al.
Publicado: (2022)

Fatal refractory cardiac arrest as presentation of systemic amyloidosis
por: Chung, Peter, et al.
Publicado: (2020)

Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response
por: Grogan, Martha, et al.
Publicado: (2017)

Lingual liability: macroglossia and dyspnoea as the harbinger of systemic AL (light-chain) cardiac amyloidosis
por: Williams, Michael Uncle, et al.
Publicado: (2018)

The prognostic value of multiparametric cardiac magnetic resonance in patients with systemic light chain amyloidosis
por: Miao, Fujia, et al.
Publicado: (2023)

T1 mapping and survival in systemic light-chain amyloidosis
por: Banypersad, Sanjay M., et al.
Publicado: (2015)

Systemic Light Chain Amyloidosis Mimicking Rheumatic Disorders
por: Rao, Rohit R., et al.
Publicado: (2016)

Multidisciplinary supportive care in systemic light chain amyloidosis
por: Maroun, Bou Zerdan, et al.
Publicado: (2022)

Evidence of Concurrent Light Chain and Transthyretin Cardiac Amyloidosis in 2 Patients
por: Donnelly, Joseph P., et al.
Publicado: (2020)

Prevalence and Treatment of Arrhythmias in Patients With Transthyretin and Light-Chain Cardiac Amyloidosis
por: Miyamoto, Masakazu, et al.
Publicado: (2023)

Significant role of magnetic resonance imaging for the diagnosis and evaluation of cardiac amyloidosis in primary light chain amyloidosis
por: Sekiguchi, Yasunobu, et al.
Publicado: (2020)

First Case of Nodular Localized Primary Cutaneous Amyloidosis Treated With Bortezomib and Dexamethasone
por: Khan, Noman Ahmed Jang, et al.
Publicado: (2021)

Potential clinical relevance of cardiac magnetic resonance to diagnose cardiac light chain amyloidosis
por: Dohy, Zsofia, et al.
Publicado: (2022)

Novel Therapies in Light Chain Amyloidosis
por: Milani, Paolo, et al.
Publicado: (2017)

DUAL expectations in light chain amyloidosis
por: Schönland, Stefan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cmn8c9fref36lnirlaand0160m